Two biosimilars of Eli Lilly’s blockbuster osteoporosis treatment Forsteo – from Hungary’s Gedeon Richter and German partner Stada – have made their debut in Europe. Forsteo (teriparatide ...

Background: This paper presents the model and results to evaluate the use of teriparatide as a first-line treatment of severe postmenopausal osteoporosis (PMO) and Glucocorticoid-induced ...

Identical cohorts of patients are simulated by the model to compare costs and benefits for teriparatide treatment, bisphosphonate treatment, and no treatment. The simulated patients are defined by ...